Longitude Capital Partners III, LLC

Average Profitability
20.32%
Insider Buys Quantity
6
Insider Buys Sum
$69.91M
Insider Sells Quantity
1
Insider Sells Sum
$11,272.66

Insider Activity of Longitude Capital Partners III, LLC

The largest purchase of all time was on 2020-07-28 and amounted to 1250000 shares of Inozyme Pharma, Inc. for $20M.

The largest sale of all time was on 2020-08-28 and amounted to 1049 shares of Molecular Templates, Inc. for $11,273.

Biography of Longitude Capital Partners III, LLC

No biography is available at this moment.

2020-08-28SaleMolecular Templates, Inc.
MTEM
10 percent owner
1,049
0.002%
$10.75$11,273-17.53%
2020-07-28PurchaseInozyme Pharma, Inc.
INZY
10 percent owner
1.25M
6.0841%
$16.00$20M+19.03%
2020-07-10Purchase89bio, Inc.
ETNB
10 percent owner
218,180
1.1029%
$27.50$6M-23.56%
2019-11-25PurchaseMolecular Templates, Inc.
MTEM
10 percent owner
937,500
1.7253%
$8.00$7.5M+23.32%
2019-11-11Purchase89bio, Inc.
ETNB
10 percent owner
1.15M
37.7365%
$16.00$18.4M+28.8%
2018-11-02PurchaseAxonics, Inc.
AXNX
10 percent owner
1.07M
15.1721%
$15.00$16M+49.27%
2018-09-21PurchaseMolecular Templates, Inc.
MTEM
10 percent owner
365,000
1.3138%
$5.50$2.01M-2.63%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.